Status:
RECRUITING
NLR AND CRP Useful as Cost-Effective Preliminary Prognostic Markers in ST-Elevation Myocardial Infarction
Lead Sponsor:
Sohag University
Conditions:
STEMI
Eligibility:
All Genders
18+ years
Brief Summary
Acute myocardial infarction (AMI) is a serious and fatal cardiovascular emergency and considered the leading cause of mortality worldwide. Atherosclerosis of coronary arteries which takes decades to ...
Detailed Description
Acute myocardial infarction (AMI) is a serious and fatal cardiovascular emergency and considered the leading cause of mortality worldwide. * Atherosclerosis of coronary arteries which takes decades t...
Eligibility Criteria
Inclusion
- Patients with age ≥18 years of either sex, with either increase in serum cardiac biomarkers or ECG are STEMI.
Exclusion
- Patients presenting with NSTEMI and unstable angina
- Patients with any of these associated conditions that can affect NLR or CRP including
- Inflammatory conditions such as collagen-vascular disorders
- Acute or chronic infectious diseases.
- Auto-immune and neoplastic diseases.
- Chronic hepatic diseases.
- Renal failure.
- Thyroid disorders.
- Previous valvular heart disease.
Key Trial Info
Start Date :
July 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06491667
Start Date
July 1 2024
End Date
December 1 2024
Last Update
July 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag university hospital
Sohag, Egypt